For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Geovax Labs Inc’s stock clocked out at $0.54, up 13.93% from its previous closing price of $0.47. In other words, the price has increased by $13.93 from its previous closing price. On the day, 2.49 million shares were traded. GOVX stock price reached its highest trading level at $0.5481 during the session, while it also had its lowest trading level at $0.4801.
Ratios:
To gain a deeper understanding of GOVX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.03 and its Current Ratio is at 2.03. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on April 15, 2025, Reiterated its Buy rating but revised its target price to $14 from $18 previously.
On April 15, 2025, Alliance Global Partners reiterated its Buy rating and also upped its target price recommendation from $15 to $8.50.
On November 11, 2024, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $15.Alliance Global Partners initiated its Buy rating on November 11, 2024, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 07 ’25 when McKee Kelly T. Jr. bought 1,107 shares for $0.67 per share. The transaction valued at 742 led to the insider holds 3,494 shares of the business.
SPENCER JOHN N JR bought 10,000 shares of GOVX for $9,800 on Apr 10 ’25. The Director now owns 11,402 shares after completing the transaction at $0.98 per share. On Apr 10 ’25, another insider, Sharkey John W., who serves as the VP, Business Development of the company, bought 6,000 shares for $0.99 each. As a result, the insider paid 5,940 and bolstered with 6,191 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOVX now has a Market Capitalization of 16384832 and an Enterprise Value of 10574959. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.23 while its Price-to-Book (P/B) ratio in mrq is 3.04. Its current Enterprise Value per Revenue stands at 1.721 whereas that against EBITDA is -0.424.
Stock Price History:
The Beta on a monthly basis for GOVX is 3.32, which has changed by -0.7747619 over the last 52 weeks, in comparison to a change of 0.17342639 over the same period for the S&P500. Over the past 52 weeks, GOVX has reached a high of $3.88, while it has fallen to a 52-week low of $0.43. The 50-Day Moving Average of the stock is -24.04%, while the 200-Day Moving Average is calculated to be -55.70%.
Shares Statistics:
It appears that GOVX traded 1.49M shares on average per day over the past three months and 1185960 shares per day over the past ten days. A total of 25.36M shares are outstanding, with a floating share count of 25.28M. Insiders hold about 0.31% of the company’s shares, while institutions hold 7.99% stake in the company. Shares short for GOVX as of 1757894400 were 3794469 with a Short Ratio of 2.55, compared to 1755216000 on 3271439. Therefore, it implies a Short% of Shares Outstanding of 3794469 and a Short% of Float of 15.040000000000001.
Earnings Estimates
Geovax Labs Inc (GOVX) is currently under the scrutiny of 4.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.16 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$0.49 and -$1.4 for the fiscal current year, implying an average EPS of -$1.09. EPS for the following year is -$1.28, with 4.0 analysts recommending between -$0.61 and -$2.54.
